A Phase I New Approaches to Neuroblastoma Therapy Study of Buthionine Sulfoximine and Melphalan With Autologous Stem Cells for Recurrent/Refractory High-Risk Neuroblastoma

Author:

Villablanca Judith G.1,Volchenboum Samuel L.2,Cho Hwangeui3,Kang Min H.3,Cohn Susan L.2,Anderson Clarke P.4,Marachelian Araz1,Groshen Susan5,Tsao-Wei Denice5,Matthay Katherine K.6,Maris John M.7,Hasenauer Charlotte E.1,Czarnecki Scarlett1,Lai Hollie8,Goodarzian Fariba8,Shimada Hiro9,Reynolds Charles Patrick3

Affiliation:

1. Department of Pediatrics, Children's Hospital Los Angeles and Keck School of Medicine; University of Southern California; Los Angeles California

2. Department of Pediatrics; University of Chicago Comprehensive Cancer Center; Chicago Illinois

3. Cancer Center and Departments of Cell Biology & Biochemistry, Pediatrics, and Medicine; Texas Tech University Health Sciences Center School of Medicine; Lubbock Texas

4. City of Hope National Medical Center; Duarte California

5. Department of Preventative Medicine Statistics, Keck School of Medicine; University of Southern California; Los Angeles California

6. Department of Pediatrics; University of California San Francisco; San Francisco California

7. Department of Pediatrics; Children's Hospital of Philadelphia; Philadelphia Pennsylvania

8. Department of Radiology; Children's Hospital Los Angeles and Keck School of Medicine; University of Southern California; Los Angeles California

9. Department of Pathology and The Saban Research Institute, Children's Hospital Los Angeles and Keck School of Medicine; University of Southern California; Los Angeles California

Funder

National Institutes of Health

Dougherty Foundation

Milken Family Foundation

Evan Dunbar Foundation

Alex Lemonade Stand

Children's Neuroblastoma Cancer Foundation

Neuroblastoma Children's Cancer Society

Douglas Michael Fuller Foundation

Because of Ezra Foundation

Publisher

Wiley

Subject

Oncology,Hematology,Pediatrics, Perinatology, and Child Health

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3